Urology News and Research

Latest Urology News and Research

Dartmouth explores glucorticoid side effects on bladder-cancer patients

In her most recent study of possible triggers of cancer among northern New England residents, Dartmouth epidemiologist Margaret R. Karagas, Ph.D., and her team identified an enhanced risk to the bladders of patients taking drugs that suppress the immune system.

27 Oct 2009

NCI funds new Center on Microenvironment and Metastasis to research on cancer

Adding potent research firepower and fresh physical perspectives to combat cancer, the National Cancer Institute (NCI) has funded the new Center on the Microenvironment and Metastasis, which will be headquartered at Cornell University.

27 Oct 2009

Study links urogenital birth defects with DDT

Women who lived in villages sprayed with DDT to reduce malaria gave birth to 33 per cent more baby boys with urogenital birth defects (UGBD) between 2004 and 2006 than women in unsprayed villages, according to research published online by the UK-based urology journal BJUI.

24 Oct 2009

DDT exposure is associated with urogenital birth defects in newborn boys

23 Oct 2009

Sectra signs distribution agreement with Attieh Medico

The Swedish IT and medical-technology company Sectra has signed a distribution agreement with Attieh Medico, a leading medical technology company in the Kingdom of Saudi Arabia.

22 Oct 2009

EMEA informs Antigenics on a negative opinion for Oncophage MAA

Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), of the European Medicines Agency (EMEA), has verbally informed the Company at an oral meeting to anticipate a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) in early-stage, localized renal cell carcinoma (kidney cancer).

21 Oct 2009

MIRP surgery carries higher risk of impotence and incontinence than traditional surgery

A new study debating the effectiveness of minimally invasive prostate surgery is not telling the whole story, warns Dr. David B. Samadi, Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology at The Mount Sinai Medical Center in New York.

21 Oct 2009

New tools needed to identify men and women at risk for the most aggressive cancers

Twenty years of screening for breast and prostate cancer - the most diagnosed cancer for women and men - have not brought the anticipated decline in deaths from these diseases, argue experts from the University of California, San Francisco and the University of Texas Health Science Center at San Antonio in an opinion piece published in the "Journal of the American Medical Association."

21 Oct 2009

Interim study analysis comparing MENOPUR with rFSH in GnRH Antagonist IVF cycles

Ferring Pharmaceuticals presented an interim study analysis indicating that MENOPUR® (menotropins for injection, USP) is effective in in vitro fertilization (IVF) cycles using a gonadotropin-releasing hormone (GnRH) antagonist. The results were presented in a poster at the 65th Annual Meeting of the American Society for Reproductive Medicine (ASRM) in Atlanta, October 17-21, 2009.

21 Oct 2009

Eclipsys' 2009 Circle of Excellence Award winners announced

Eclipsys Corporation®, The Outcomes Company®, today announced the winners of its 2009 Circle of Excellence Award program.

21 Oct 2009

Testicular cancer survivors at risk of effective treatment

Testicular cancer survivors can face an increased risk of long-term illness, not because of the malignancy, but the highly effective treatment they receive, according to a study in the urology journal BJUI.

20 Oct 2009

Study explores the link between LUTS and depression, anxiety disorders, sexual trauma

Depression, anxiety disorders and sexual trauma have all been implicated as risk factors in lower urinary tract symptoms (LUTS) such as incontinence and overactive bladder.

20 Oct 2009

Update from Endo Pharmaceuticals regarding its New Drug Application for FORTESTA

Endo Pharmaceuticals today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for FORTESTA(TM) (testosterone) 2% Gel for men diagnosed with low testosterone (Low T), also known as hypogonadism.

19 Oct 2009

BJUI: Testicular cancer survivors face an increased risk of long-term illness due to effective treatment

19 Oct 2009

HealthScape Consumer to analyze patient and consumer data

Healthy Advice Networks, the nation's leading provider of physician office-based patient-education programs, announces a groundbreaking measurement program to track consumer purchase behavior, not just purchase intent, for OTC and consumer health brands.

19 Oct 2009

Robotically assisted minimally invasive bladder reconstructive surgery on children performed

For the first time, a surgical robot has been used to perform minimally invasive reconstructive surgery on five children whose bladder was dysfunctional because they were born with spina bifida [incomplete formation of the spine or spinal cord].

18 Oct 2009

Co-promotion agreement to promote Prosed DS to urologists and retail pharmacists

Timm Medical Technologies, Inc., a specialist Urology company, announced today its exclusive co-promotion agreement with Ferring Pharmaceuticals Inc., a Swiss-based biopharmaceutical company, for Prosed® DS (methenamine, phenyl salicylate, methylene blue, benzoic acid, hyoscyamine sulfate) in the United States.

15 Oct 2009

AbbeyMoor Medical's The Spanner temporary prostatic stent insertion procedure receives Category I CPT code

AbbeyMoor Medical Inc. announced today they have been granted a Category I CPT code by the American Medical Association (AMA) for The Spanner(TM) temporary prostatic stent insertion procedure. This important action, effective in January 2010, upgrades The Spanner from a Category III emerging technology procedure code to a Category I procedure code for established procedures.

15 Oct 2009

More than half RCTs do not report vital information about study populations race, says study

A new study recently published online by the American Heart Journal shows that more than half of all randomized clinical trials, or RCTs, for cardiovascular disease are not reporting vital information about the study populations race or ethnicity. NYU School of Medicine researchers found that out of the 156 cardiovascular disease RCTs analyzed, only 35% of trials reported any information on race or ethnicity between 1970 and 2006. From 2000 to 2006, 46% of trials included that information.

15 Oct 2009

Researchers develop magneto-nano sensor chip to detect cancer

Searching for biomarkers that can warn of diseases such as cancer while they are still in their earliest stage is likely to become far easier thanks to an innovative biosensor chip developed by Stanford University researchers.

14 Oct 2009

Urology News and Research

Latest Urology News and Research

Dartmouth explores glucorticoid side effects on bladder-cancer patients

NCI funds new Center on Microenvironment and Metastasis to research on cancer

Study links urogenital birth defects with DDT

DDT exposure is associated with urogenital birth defects in newborn boys

Sectra signs distribution agreement with Attieh Medico

EMEA informs Antigenics on a negative opinion for Oncophage MAA

MIRP surgery carries higher risk of impotence and incontinence than traditional surgery

New tools needed to identify men and women at risk for the most aggressive cancers

Interim study analysis comparing MENOPUR with rFSH in GnRH Antagonist IVF cycles

Eclipsys' 2009 Circle of Excellence Award winners announced

Testicular cancer survivors at risk of effective treatment

Study explores the link between LUTS and depression, anxiety disorders, sexual trauma

Update from Endo Pharmaceuticals regarding its New Drug Application for FORTESTA

BJUI: Testicular cancer survivors face an increased risk of long-term illness due to effective treatment

HealthScape Consumer to analyze patient and consumer data

Robotically assisted minimally invasive bladder reconstructive surgery on children performed

Co-promotion agreement to promote Prosed DS to urologists and retail pharmacists

AbbeyMoor Medical's The Spanner temporary prostatic stent insertion procedure receives Category I CPT code

More than half RCTs do not report vital information about study populations race, says study

Researchers develop magneto-nano sensor chip to detect cancer

Innovation in neuroscience drug discovery - eBook eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Urology News and Research

Latest Urology News and Research

Innovation in neuroscience drug discovery - eBook eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in